Active Immune Phenotype in Head and Neck Cancer: Reevaluating the Iso-Effect Fractionation Based on the Linear Quadratic (LQ) Model-A Narrative Review.
Mireștean CC, Iancu RI, Iancu DPT.
Curr Oncol. 2023 May 8;30(5):4805-4816. doi: 10.3390/curroncol30050362.
PMID:37232820
Use of the linear-quadratic radiobiological model for quantifying kidney response in targeted radiotherapy.
Dale R.
Cancer Biother Radiopharm. 2004 Jun;19(3):363-70. doi: 10.1089/1084978041425070.
The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
van Leeuwen CM, Oei AL, Crezee J, Bel A, Franken NAP, Stalpers LJA, Kok HP.
Radiat Oncol. 2018 May 16;13(1):96. doi: 10.1186/s13014-018-1040-z.
PMID:29769103
Radiobiology of brachytherapy: The historical view based on linear quadratic model and perspectives for optimization.
Chargari C, Van Limbergen E, Mahantshetty U, Deutsch É, Haie-Méder C.
Cancer Radiother. 2018 Jun;22(4):312-318. doi: 10.1016/j.canrad.2017.11.011. Epub 2018 May 30.
PMID:29858137
Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.
Shibamoto Y, Otsuka S, Iwata H, Sugie C, Ogino H, Tomita N.
J Radiat Res. 2012;53(1):1-9. doi: 10.1269/jrr.11095. Epub 2011 Oct 14.